Evidence map›Paper›PMID 30853364›Full record

ArticleAmerican journal of obstetrics and gynecology2019

Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.

Vrunda B Desai, Jason D Wright, Cary P Gross, Haiqun Lin, Francis P Boscoe, Lindsey M Hutchison, Peter E Schwartz, Xiao Xu

Open access · greenAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hysterectomy for cervical intraepithelial neoplasia: A retrospective observational multi-institutional study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Article
  18. Unexpected location of endometrial adenocarcinoma - a case report.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Vrunda B DesaiDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT; CooperSurgical Inc, Trumbull, CT.
Jason D WrightDepartment of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY.
Cary P GrossDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, New Haven, CT.
Haiqun LinDepartment of Biostatistics, Yale School of Public Health, New Haven, CT.
Francis P BoscoeNew York State Cancer Registry, New York State Department of Health, Albany, NY.
Lindsey M HutchisonNew York State Cancer Registry, New York State Department of Health, Albany, NY.
Peter E SchwartzDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT.
Xiao XuDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, New Haven, CT. Electronic address: xiao.xu@yale.edu.
Yale University · USNew York State Department of Health · USYale Cancer Center · USColumbia University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Occult Uterine Cancer and Power Morcellation in Hysterectomy and MyomectomyR01HS024702 · AHRQ · YALE UNIVERSITY · PI XU, XIAO · 2016 to 2018
$1.0M
AHRQ HHS R01 HS024702NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundOccult uterine cancer at the time of benign hysterectomy poses unique challenges in patient care. There is large variability and uncertainty in estimated risk of occult uterine cancer in the literature and prior research often did not differentiate/include all subtypes.

objectivesTo thoroughly examine the prevalence of occult uterine cancer in a large population-based sample of women undergoing hysterectomy for presumed benign indications and to identify associated risk factors. STUDY

designUsing the New York Statewide Planning and Research Cooperative System database, we identified 229,536 adult women who underwent an inpatient or outpatient hysterectomy for benign indications during the period October 1, 2003 to December 31, 2013 at civilian hospitals and ambulatory surgery centers throughout the state. Diagnosis of corpus uteri cancer within 28 days after the index hysterectomy was determined using linked state cancer registry data. We estimated the prevalence of occult uterine cancer (overall and by subtype) and developed and validated risk prediction models using a random split sample approach.

resultsOverall, 0.96% (95% confidence interval: 0.92-1.00%) of the women had occult uterine cancer, including 0.75% (95% confidence interval: 0.71-0.78%) with endometrial carcinoma and 0.22% (95% confidence interval: 0.20-0.23%) with uterine sarcoma. The prevalence of leiomyosarcoma was 0.15% (95% confidence interval: 0.13-0.17%). Seventy-one percent of the endometrial carcinomas and 58.0% of the uterine sarcomas were at localized stage. The risk for occult uterine cancer ranged from 0.10% in women aged 18-29 years to 4.40% in women aged ≥75 years; and varied from 0.14% in women undergoing hysterectomy for endometriosis to 0.62% for uterine fibroids and 8.43% for postmenopausal bleeding. The risk of occult uterine cancer was also significantly associated with race/ethnicity, obesity, comorbidity, and personal history of malignancy. Prediction models incorporating these risk factors had high negative predictive values (99.8% for endometrial carcinoma and 99.9% for uterine sarcoma) and good rule-out accuracy despite low positive predictive value.

conclusionsIn women undergoing hysterectomy for presumed benign indications, 0.96% had unexpected uterine cancer. Patient characteristics such as age, surgical indication, and medical history may help guide risk stratification.

Indexed as

HysterectomyIncidental FindingsAdolescentAdultAgedAsianBlack or African AmericanComorbidityEndometrial NeoplasmsEndometriosisEthnicityFemaleHispanic or LatinoHumansLeiomyomaLeiomyosarcomaendometrial carcinomahysterectomyleiomyosarcomaoccult uterine cancerrisk predictionuterine sarcoma

Identifiers

PMID30853364
PMCPMC7006101
OpenAlexW2921259065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.